• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成因子的血清水平表明镰状细胞病成人患者处于促血管生成状态。

Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease.

作者信息

Duits Ashley J, Rodriguez Tati, Schnog John-John B

机构信息

Immunology Laboratory Department, Red Cross Blood Bank Foundation, Curaçao, Netherlands Antilles.

出版信息

Br J Haematol. 2006 Jul;134(1):116-9. doi: 10.1111/j.1365-2141.2006.06103.x.

DOI:10.1111/j.1365-2141.2006.06103.x
PMID:16803577
Abstract

Hypoxia-induced angiogenesis may play an important role in the pathophysiology of sickle cell disease (SCD). Serum levels of angiopoietin (Ang)-1, Ang-2, vascular endothelial growth factor, placenta growth factor (PlGF), soluble tunica intima endothelial kinase 2 (sTIE2), erythropoietin (EPO) and endothelial activation markers (soluble vascular adhesion molecule-1, soluble intercellular adhesion molecule-1) were determined in controls, HbSS (n = 35) and HbSC (n = 23) patients. In the asymptomatic phase, serum Ang-2 (P < 0.001), EPO (P < 0.001) and sTIE2 (P = 0.03) were elevated in patients. During painful crises, increased Ang-2 (P < 0.001) and PlGF (P = 0.04) occurred in HbSS and Ang-2 (P = 0.05) in HbSC patients. These results indicate a pro-angiogenic state in SCD, mainly because of elevated Ang-2 levels.

摘要

缺氧诱导的血管生成可能在镰状细胞病(SCD)的病理生理学中起重要作用。在对照组、HbSS患者(n = 35)和HbSC患者(n = 23)中测定了血清血管生成素(Ang)-1、Ang-2、血管内皮生长因子、胎盘生长因子(PlGF)、可溶性内膜内皮激酶2(sTIE2)、促红细胞生成素(EPO)和内皮激活标志物(可溶性血管细胞黏附分子-1、可溶性细胞间黏附分子-1)的水平。在无症状期,患者血清中的Ang-2(P < 0.001)、EPO(P < 0.001)和sTIE2(P = 0.03)升高。在疼痛危象期间,HbSS患者的Ang-2(P < 0.001)和PlGF(P = 0.04)升高,HbSC患者的Ang-2(P = 0.05)升高。这些结果表明SCD存在促血管生成状态,主要是由于Ang-2水平升高。

相似文献

1
Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease.血管生成因子的血清水平表明镰状细胞病成人患者处于促血管生成状态。
Br J Haematol. 2006 Jul;134(1):116-9. doi: 10.1111/j.1365-2141.2006.06103.x.
2
Increased circulating PEDF and low sICAM-1 are associated with sickle cell retinopathy.循环中色素上皮衍生因子(PEDF)水平升高及可溶性细胞间黏附分子-1(sICAM-1)水平降低与镰状细胞视网膜病变相关。
Blood Cells Mol Dis. 2015 Jan;54(1):33-7. doi: 10.1016/j.bcmd.2014.08.003. Epub 2014 Aug 29.
3
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.增殖性镰状视网膜病变中的血管生成素/Tie-2系统:与血管内皮生长因子、其可溶性受体Flt-1及血管性血友病因子的关系,以及与激光治疗效果的关系。
Br J Ophthalmol. 2005 Jul;89(7):815-9. doi: 10.1136/bjo.2004.058164.
4
Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].高血压患者血管生成素1和2、血管生成素受体Tie-2及血管内皮生长因子水平异常:与靶器官损害的关系[盎格鲁-斯堪的纳维亚心脏结局试验(ASCOT)的一项子研究]
J Intern Med. 2005 Oct;258(4):336-43. doi: 10.1111/j.1365-2796.2005.01550.x.
5
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.充血性心力衰竭患者血浆血管生成素-1、血管生成素-2及血管生成素受体Tie-2水平
J Am Coll Cardiol. 2004 Feb 4;43(3):423-8. doi: 10.1016/j.jacc.2003.08.042.
6
Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.缺氧诱导因子-1通过诱导多种血管生成因子来介导培养的血管内皮细胞的激活。
Circ Res. 2003 Oct 3;93(7):664-73. doi: 10.1161/01.RES.0000093984.48643.D7. Epub 2003 Sep 4.
7
Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.急性冠状动脉综合征患者血浆血管生成素-1、血管生成素-2、血管生成素受体Tie-2及血管内皮生长因子水平
Circulation. 2004 Oct 19;110(16):2355-60. doi: 10.1161/01.CIR.0000138112.90641.7F. Epub 2004 Aug 9.
8
Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.通过在小鼠皮肤癌发生过程中对Ha-ras的调控、胎盘生长因子和血管生成素表达来调节血管生成反应。
Mol Carcinog. 2003 Jun;37(2):83-90. doi: 10.1002/mc.10126.
9
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.糖尿病视网膜病变中的血浆血管内皮生长因子、血管生成素-2和可溶性血管生成素受体Tie-2:激光光凝和血管紧张素受体阻断的作用
Br J Ophthalmol. 2004 Dec;88(12):1543-6. doi: 10.1136/bjo.2004.048587.
10
Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features.自身免疫性甲状腺疾病中血管生成分子的血清水平及其与实验室和临床特征的相关性。
J Clin Endocrinol Metab. 2009 Apr;94(4):1145-53. doi: 10.1210/jc.2008-1571. Epub 2009 Jan 13.

引用本文的文献

1
Angiopoietin-2 is associated with sickle cell complications, including stroke risk, and decreases with hydroxyurea therapy.血管生成素-2与镰状细胞并发症相关,包括中风风险,并且在羟基脲治疗后会降低。
Blood Vessel Thromb Hemost. 2024 Feb 8;1(1):100001. doi: 10.1016/j.bvth.2024.100001. eCollection 2024 Mar.
2
The role of red blood cell characteristics and viscosity in sickle cell retinopathy and maculopathy.红细胞特征和黏度在镰状细胞视网膜病变及黄斑病变中的作用。
Br J Haematol. 2025 Jun;206(6):1796-1805. doi: 10.1111/bjh.20124. Epub 2025 Apr 29.
3
Exploration of Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) and Its Association with Proangiogenic Mediators in Sickle Cell Disease: A Potential Player in the Pathogenesis of the Disease.
富含亮氨酸的α-2糖蛋白1(LRG1)及其与镰状细胞病中促血管生成介质的关联研究:疾病发病机制中的潜在作用因子
Turk J Haematol. 2025 May 22;42(2):100-107. doi: 10.4274/tjh.galenos.2025.2025.0441. Epub 2025 Apr 15.
4
Circulating biomarkers associated with pediatric sickle cell disease.与小儿镰状细胞病相关的循环生物标志物。
Front Mol Biosci. 2024 Dec 19;11:1481441. doi: 10.3389/fmolb.2024.1481441. eCollection 2024.
5
Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease.镰状细胞病患者的血浆炎症和血管生成蛋白分析
Br J Haematol. 2025 Mar;206(3):954-964. doi: 10.1111/bjh.19970. Epub 2025 Jan 1.
6
Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?我们能否使用生物标志物来识别镰状细胞病急性疼痛风险人群?
Expert Rev Hematol. 2024 Aug;17(8):411-418. doi: 10.1080/17474086.2024.2372322. Epub 2024 Jul 5.
7
Sublingual Microcirculation Specificity of Sickle Cell Patients: Morphology of the Microvascular Bed, Blood Rheology, and Local Hemodynamics.镰状细胞病患者舌下微循环的特异性:微血管床形态、血液流变学和局部血液动力学。
Int J Mol Sci. 2023 Feb 11;24(4):3621. doi: 10.3390/ijms24043621.
8
Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia.输血依赖型和非输血依赖型地中海贫血的血液流变学特征及慢性炎症标志物
Front Mol Biosci. 2023 Jan 9;9:1108896. doi: 10.3389/fmolb.2022.1108896. eCollection 2022.
9
Decreased parasite burden and altered host response in children with sickle cell anemia and severe anemia with malaria.镰状细胞贫血合并严重疟疾贫血患儿寄生虫负荷减少和宿主反应改变。
Blood Adv. 2021 Nov 23;5(22):4710-4720. doi: 10.1182/bloodadvances.2021004704.
10
Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.血红素诱导镰状细胞小鼠的 IL-6 和心脏肥厚基因转录本。
Front Immunol. 2020 Aug 21;11:1910. doi: 10.3389/fimmu.2020.01910. eCollection 2020.